Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2020 08:00 ET | Source: Beta Bionics

Beta Bionics Appoints Martha Aronson and Sean Carney to Its Board as Independent Directors

WEST CONCORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas...
December 10, 2019 02:00 ET | Source: Beta Bionics

Beta Bionics Receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System

The iLet is a pocket-sized, wearable investigational medical device that autonomously controls blood sugar in people with diabetes and other conditions -- it is the world’s first bionic pancreas...
December 03, 2019 08:00 ET | Source: Beta Bionics

Encouraging Results of Pilot Study Testing Bionic Pancreas in Cystic Fibrosis-Related Diabetes Published in Journal of Cystic Fibrosis

A pilot study performed by researchers at the Massachusetts General Hospital tested autonomous glycemic control using the bionic pancreas system in both insulin-only and bihormonal...
July 17, 2019 08:00 ET | Source: Beta Bionics

Beta Bionics and ConvaTec Announce Partnership to Bring Unomedical Infusion Set Portfolio to the iLet™ Bionic Pancreas System

ConvaTec is a leading global manufacturer of widely popular infusion sets offering a variety of patient choice Beta Bionics is developer of the iLet Bionic Pancreas System and is committed to device...
July 01, 2019 14:50 ET | Source: Beta Bionics

Beta Bionics Announces Closing of a $63 Million Series B2 Financing, Bringing the Total Series B and B2 Financings to $126 Million

The round was co-led by new investors Perceptive Advisors and Soleus CapitalNew investor Farallon Capital also participated in the round, as did previous Series B investors RTW Investments, ArrowMark...
January 08, 2019 16:19 ET | Source: Beta Bionics

Beta Bionics Announces Final Closing of Its $63 Million Series B Financing

New investors include ArrowMark, LifeSci Venture Partners, and strategic partner, DexcomRTW made an additional Series B investmentStrategic partner, Zealand Pharma completed $5 million Series B...
October 09, 2018 12:46 ET | Source: Beta Bionics

Beta Bionics Awarded Up to $2 Million NIH Small Business Innovation Research (SBIR) Grant

Award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Grant provides up to $2 million in funding over the next 24 months under the Fast-Track mechanism (pending...
September 17, 2018 09:16 ET | Source: Beta Bionics

Beta Bionics Secures an Initial $50 Million Series B Round

The round was led by Eventide Asset ManagementOther institutional investors in Series B include RTW InvestmentsCorporate strategic partner and Series A investor, Novo Nordisk, has also participated in...
July 12, 2018 08:00 ET | Source: Beta Bionics

Beta Bionics Announces Start of Home-Use Clinical Trials with the iLet™ Bionic Pancreas System and Receives IDE Approval from the FDA to Expand its Clinical Trials to Include the Senseonics Eversense CGM Integrated into the iLet

The Beta Bionics iLet Bionic Pancreas System is now approved for clinical trials in adults with type 1 diabetes (T1D) using two highly accurate continuous glucose monitoring (CGM) systems: the Dexcom...
May 21, 2018 08:00 ET | Source: Beta Bionics

Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLet™ Bionic Pancreas System

First trial to test Fiasp® – Novo Nordisk’s latest formulation of fast-acting insulin aspart – using autonomous insulin delivery The bionic pancreas will also be tested with the conventional...